Education | Laboratory Personnel | General Research Interest | Selected Research Projects
Research and Clinical Interests | Major Specialized Equipment Items Available | Selected Publications
TCSVM Faculty

Charles B. Shoemaker
Professor
Department of Infectious Disease and Global Health
Infectious Diseases
Phone:508-887-4324
Fax: 508-839-7911
Email: charles.shoemaker@tufts.edu
Dept. URL: http://www.tufts.edu/vet/idgh/
Lab URLs: Shoemaker bio
 Shoemaker/Skelly Lab
 Molecular Helminthology Lab

Education
PhD - University of Iowa - 1979
BS - University of NH - 1975

Back to the Top

Laboratory Personnel

Shoemaker/Skelly Lab:

  • Dr. Greice Krautz-Peterson
  • Dr. Akram d'Adara
  • Ms. Jacque Tremblay
  • Ms. Michelle Debatis
  • Dr. Mary Drozd
  • Mr. Qiang Wang


Back to the Top

General Research Interest

Research Sponsor Interest


  • Privately Funded Research
  • Federally Funded Research
Back to the Top

Selected Research Projects

  1. Probing the helminth host/parasite interface with phage-displayed antibodies
  2. VHH-based neutralizing agents for antitoxin therapy
  3. Agents that target toxins for proteasome degradation
Back to the Top

Selected Publications

  1. Shoemaker CB, Oyler GA. 2013. Persistence of botulinum neurotoxin inactivation of nerve function. Curr Top Microbiol Immunol.364:179-96. PMCID: PMC3528263.

  2. Krautz-Peterson, Oyler GA, Feng H, Shoemaker CB. 2012. Retargeting Clostridium difficile toxin B to neuronal cells as a potential vehicle for cytosolic delivery of therapeutic biomolecules to treat botulism. J. Toxicol. 2012:760142.

  3. Mukherjee J, Tremblay JM, Leysath CE, Ofori K, Baldwin K, Feng X, Bedenice D, Webb RP, Wright PM, Smith LA, Tzipori S, Shoemaker CB. 2012. A novel strategy for development of recombinant antitoxin therapeutics tested in a mouse botulism model. PLoS ONE. 7(1):e29941.

  4. Gu S, Rumpel S, Zhou J, Strotmeier J, Bigalke H, Perry K, Shoemaker CB, Rummel A, Jin R. 2012. Botulinum neurotoxin is shielded by NTNHA in an interlocked complex. Science. 335:977-981.

  5. Kuo CL, Oyler GA, Shoemaker CB. 2011. Accelerated neuronal cell recovery from botulinum neurotoxin intoxication by targeted ubiquitination. PLoS ONE. 6(5):e20352.

  6. Tsai YC, Maditz R, Kuo CL, Fishman PS, Shoemaker CB, Oyler GA, Weissman AM. 2010. Targeting botulinum neurotoxin persistence by the ubiquitin-proteasome system. Proc. Natl. Acad. Sci. USA. 107:16554-9. PMCID: PMC2944746.

  7. Tremblay JM, Kuo CL, Abeijon C, Sepulveda J, Oyler G, Hu X, Jin MM, Shoemaker CB. 2010. Camelid single domain antibodies (VHHs) as neuronal cell intrabody binding agents and inhibitors of Clostridium botulinum neurotoxin (BoNT) proteases. Toxicon. 56:990-8. PMCID: PMC2946066.

  8. Krautz-Peterson G, Simoes M, Faghiri Z, Ndegwa D, Oliveira G, Shoemaker CB, Skelly PJ. 2010. Suppressing glucose transporter gene expression in schistosomes impairs parasite feeding and decreases survival in the mammalian host. Plos Pathogens. 6:e1000932. PMCID: PMC2880588.

  9. Sepulveda J, Tremblay JM, Skelly PJ, Shoemaker CB. 2010. Schistosoma mansoni host-exposed surface antigens characterized by sera and recombinant antibodies from schistosomiasis resistant rats. Int. J. Parasitol. 40:1407-17. PMCID: PMC2939210.

  10. Sepulveda J, Mukherjee J, Tzipori S, Simpson LL, Shoemaker CB. 2010. Efficient serum clearance of Botulinum neurotoxin achieved using a pool of small antitoxin binding agents. Infection and Immunity. 78:756-63. PMCID: PMC2812214.

  11. Kuo CL, Oyler G, Shoemaker CB. 2010. Lipid and cationic polymer based transduction of botulinum holotoxin, or toxin protease alone, extends the target cell range and improves the efficiency of intoxication. Toxicon. 55:619-29. PMCID: PMC2813905.

  12. Maass DR, Harrison GB, Grant WN, Hein WR, Shoemaker CB. 2009. Intraspecific epitopic variation in a carbohydrate antigen exposed on the surface of Trichostrongylus colubriformis infective L3 larvae. PLoS Pathogens. Sep;5:e1000597. PMCID: PMC2742895.

Back to the Top